Literature DB >> 20352534

Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.

LianDong Hu1, Qianbin Xing, Jian Meng, Chuang Shang.   

Abstract

In this study, solid lipid nanoparticles (SLNs) were successfully prepared by an ultrasonic and high-pressure homogenization method to improve the oral bioavailability of the poorly water-soluble drug cryptotanshinone (CTS). The particle size and distribution, drug loading capacity, drug entrapment efficiency, zeta potential, and long-term physical stability of the SLNs were characterized in detail. A pharmacokinetic study was conducted in rats after oral administration of CTS in different SLNs, and it was found that the relative bioavailability of CTS in the SLNs was significantly increased compared with that of a CTS-suspension. The incorporation of CTS in SLNs also markedly changes the metabolism behavior of CTS to tanshinone IIA. These results indicate that CTS absorption is enhanced significantly by employing SLN formulations, and SLNs represent a powerful approach for improving the oral absorption of poorly soluble drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352534      PMCID: PMC2902353          DOI: 10.1208/s12249-010-9410-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  23 in total

1.  Cytotoxic and aromatic constituents from Salvia miltiorrhiza.

Authors:  Ming-Jaw Don; Chien-Chang Shen; Wan-Jr Syu; Yi-Huei Ding; Chang-Ming Sun
Journal:  Phytochemistry       Date:  2005-12-20       Impact factor: 4.072

2.  Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.

Authors:  HouLi Li; XiaoBin Zhao; YuKun Ma; GuangXi Zhai; LingBing Li; HongXiang Lou
Journal:  J Control Release       Date:  2008-10-12       Impact factor: 9.776

3.  Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza.

Authors:  B Y Kang; S W Chung; S H Kim; S Y Ryu; T S Kim
Journal:  Immunopharmacology       Date:  2000-09

Review 4.  Active secretion and enterocytic drug metabolism barriers to drug absorption.

Authors:  V J Wacher; L Salphati; L Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

5.  Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression.

Authors:  Dao-Zhong Jin; Lin-Lin Yin; Xin-Quan Ji; Xing-Zu Zhu
Journal:  Eur J Pharmacol       Date:  2006-08-17       Impact factor: 4.432

6.  Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS).

Authors:  Haiping Hao; Guangji Wang; Peng Li; Jing Li; Zuoqi Ding
Journal:  J Pharm Biomed Anal       Date:  2005-09-19       Impact factor: 3.935

7.  Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.

Authors:  Prabagar Balakrishnan; Beom-Jin Lee; Dong Hoon Oh; Jong Oh Kim; Young-Im Lee; Dae-Duk Kim; Jun-Pil Jee; Yong-Bok Lee; Jong Soo Woo; Chul Soon Yong; Han-Gon Choi
Journal:  Int J Pharm       Date:  2009-03-19       Impact factor: 5.875

8.  Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.

Authors:  Yaping Chen; Yi Lu; Jianming Chen; Jie Lai; Jing Sun; Fuqiang Hu; Wei Wu
Journal:  Int J Pharm       Date:  2009-04-24       Impact factor: 5.875

9.  Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.

Authors:  Li Yang; Yehui Geng; Hao Li; Yu Zhang; Jinsong You; Yanyan Chang
Journal:  Pharmazie       Date:  2009-02       Impact factor: 1.267

10.  Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.

Authors:  Michael Kennedy; Jack Hu; Ping Gao; Lan Li; Alana Ali-Reynolds; Ben Chal; Vicki Gupta; Chandra Ma; Nidhi Mahajan; Anna Akrami; Sekhar Surapaneni
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

View more
  16 in total

1.  Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.

Authors:  Bilal S Abuasal; Courtney Lucas; Breanne Peyton; Alaadin Alayoubi; Sami Nazzal; Paul W Sylvester; Amal Kaddoumi
Journal:  Lipids       Date:  2012-01-24       Impact factor: 1.880

Review 2.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

3.  Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.

Authors:  Gayathri Heenatigala Palliyage; Noor Hussein; Michael Mimlitz; Catherine Weeder; Marya Hassan A Alnasser; Somnath Singh; Andrew Ekpenyong; Amit K Tiwari; Harsh Chauhan
Journal:  Pharm Res       Date:  2021-05-12       Impact factor: 4.200

4.  Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.

Authors:  Su Li; Zhaoshuai Ji; Meijuan Zou; Xin Nie; Yijie Shi; Gang Cheng
Journal:  AAPS PharmSciTech       Date:  2011-08-03       Impact factor: 3.246

Review 5.  Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine.

Authors:  Thirumurugan Gunasekaran; Tedesse Haile; Tedele Nigusse; Magharla Dasaratha Dhanaraju
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

Review 6.  Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Authors:  Surajit Das; Anumita Chaudhury
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

7.  Effect of squalane on mebendazole-loaded Compritol® nanoparticles.

Authors:  Richard A Graves; Grace A Ledet; Cedric A Nation; Yashoda V Pramar; Levon A Bostanian; Tarun K Mandal
Journal:  J Biomater Sci Polym Ed       Date:  2015-07-09       Impact factor: 3.517

8.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

Review 9.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

10.  Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability.

Authors:  Arjun Narala; Kishan Veerabrahma
Journal:  J Pharm (Cairo)       Date:  2013-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.